Related Experiment Video
Updated: May 5, 2026

Establishment of Human Epithelial Enteroids and Colonoids from Whole Tissue and Biopsy
Published on: March 6, 2015
Characterization of a novel cell line established from mice gastrointestinal stromal model by chemical induction
Zhan Zhao1, Shenghui Qiu2, Xiangwei Zhang1
1Department of General Surgery, The First Affiliated Hospital of Jinan University, 510632, Guangzhou, Guangdong, PR China.
Background:
Gastrointestinal stromal tumors (GISTs) are a type of tumor that originates from gastrointestinal mesenchymal tissue. Although several somatic or germline mutation GIST mice were established, however, there is still a lack of an authentic mice GIST cell lines for further experimental study.
Methods:
We developed a chemically induced C57BL/6 J GIST model using 3- methylcholanthrene. Tumor characteristics were confirmed through histology and IHC. Primary cells were isolated to establish the mGSTc01 cell line, and molecular profiling was conducted. Additionally, we established GIST model in immunocompetent mice to evaluate their sensitivity to imatinib.
Results:
Our study successfully developed a chemically induced murine GIST model, characterized by positive staining of c-kit and DOG-1. The mGSTc01 monoclonal cell line exhibited slender morphology and expressed the c-kit marker, Whole exome sequencing uncovered mutations of Lamb1, MMP9, and c-kit in GIST cells and provided a detailed picture of the entire genome's copy number variations. RNA sequencing indicated genes associated with cell adhesion and focal adhesion were enriched in mGSTc01 cells. The mGSTc01 cells demonstrated obvious malignant behaviors, notably elevated migration, adhesion, and proliferation. In immunocompetent mice, subcutaneous xenografts not only reserved the aggressive phenotype but also displayed a response to imatinib, underscoring the model's applicability for advancing therapeutic research.
Conclusion:
We firstly established a mGSTc01 cell line derived from C57BL/6 J mice GIST tumor offers, which closely mimicking human disease characteristics. It is a potent platform for investigating tumor microenvironment of GIST in mice model, and provides a novel way for new therapeutic discoveries in GIST.
Insights
Researchers developed a new mouse model for gastrointestinal stromal tumors (GISTs) using a chemically induced cell line, mGSTc01. This model closely mimics human GIST and responds to imatinib, offering a platform for new cancer therapies.
Area of Science:
- Oncology
- Gastroenterology
- Translational Research
Background:
- Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms.
- Existing mouse models lack authentic GIST cell lines for comprehensive study.
- Need for robust preclinical models to understand GIST pathogenesis and treatment.
Purpose of the Study:
- To develop and characterize a novel, chemically induced mouse model for GIST.
- To establish and validate a GIST cell line (mGSTc01) from this model.
- To assess the therapeutic response of the GIST model to imatinib.
Main Methods:
- Chemical induction of GIST in C57BL/6 J mice using 3-methylcholanthrene.
- Histology, immunohistochemistry (IHC), and molecular profiling (WES, RNA-seq) of tumors and cell lines.
- Establishment and characterization of the mGSTc01 cell line, including in vivo xenograft studies.
Main Results:
- Successful development of a chemically induced murine GIST model with c-kit and DOG-1 expression.
- The mGSTc01 cell line exhibited malignant behaviors (migration, adhesion, proliferation) and key mutations (Lamb1, MMP9, c-kit).
- GIST xenografts in immunocompetent mice responded to imatinib, validating the model's therapeutic relevance.
Conclusions:
- The mGSTc01 cell line, derived from a chemically induced GIST model, accurately mimics human GIST characteristics.
- This novel cell line and mouse model provide a valuable platform for GIST research.
- Enables further investigation into the tumor microenvironment and facilitates discovery of new GIST therapies.
More Related Videos
07:20A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
07:21Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022